MedTrace Logo

Urine NT-ProBNP in Neonatal Respiratory Distress

NCT02020993 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2014-01-06

No results posted yet for this study

Summary

There is a need for a biochemical marker in addition to clinical condition which will help the physician to understand the clinical progress of the disease.

Urine Nt-proBNP, which does not need any blood sampling and can be collected easily, has not been evaluated for respiratory distress in newborn.

The investigators aim to evaluate the prognostic value of urine NT-proBNP in respiratory diseases in newborns by a controlled trial.

Conditions

  • Neonatal Respiratory Distress

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Begüm Atasay, Professor · Ankara University

Eligibility

Min Age
1 Day
Max Age
7 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-12-31
Completion
2015-01-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02020993 on ClinicalTrials.gov